Gene Therapy Is Nearing a Major Breakthrough

After decades of research and development, gene therapy is rapidly emerging as one of the most exciting areas in biotechnology—and generating new hope for patients with certain rare and often deadly inherited diseases. Replacement gene therapy that uses neutered viruses to deliver healthy genes to the body is particularly promising, given its potential to cure a range of disorders with the administration of a single treatment.

The first regulatory approval for this technology could come as soon as January, if the Food and Drug Administration gives the go-ahead to


Spark Therapeutics



ONCE 2.3530240751614797%



Spark Therapeutics Inc.


U.S.: Nasdaq


USD87.1536


2.0036
2.3530240751614797%



/Date(1506360058272-0500)/


Volume (Delayed 15m)
:
169441




P/E Ratio
N/A

Market Cap
3111892077.89765


Dividend Yield
N/A

Rev. per Employee
95602.2









More quote details and news »


Article Source…

Leave a Reply

Your email address will not be published. Required fields are marked *